Publications by authors named "Lauren Milroy"

Article Synopsis
  • SARS-CoV-2 Omicron variants may affect how well vaccines work and how long immunity lasts, prompting a study on the effectiveness of the Pfizer-BioNTech vaccine among different age groups in the U.S.
  • From January 16 to May 28, 2022, researchers analyzed COVID-19 infection rates relative to vaccination status across multiple jurisdictions, tracking declines in vaccine effectiveness over time.
  • Results showed lower vaccine protection in younger age groups, particularly those aged 5-11, and a general decline in effectiveness for all ages as time since vaccination increased, indicating a need to monitor waning immunity during the Omicron surge.
View Article and Find Full Text PDF
Article Synopsis
  • Reinfections of SARS-CoV-2 in the U.S. have become more common, especially during the Omicron variant period, rising from 2.7% during Delta to 28.8% in Omicron BQ.1/BQ.1.1.
  • Hospitalizations and deaths linked to reinfections also increased significantly, going from 1.9% and 1.2% of COVID-19-related cases during Delta, to 17.0% and 12.3% during Omicron BQ.1/BQ.1.1.
  • Younger adults (18-49 years) had higher rates of reinfections compared to older adults (≥50 years), and it's crucial to stay updated on vaccinations
View Article and Find Full Text PDF

Since May 2022, approximately 20,000 cases of monkeypox have been identified in the United States, part of a global outbreak occurring in approximately 90 countries and currently affecting primarily gay, bisexual, and other men who have sex with men (MSM) (1). Monkeypox virus (MPXV) spreads from person to person through close, prolonged contact; a small number of cases have occurred in populations who are not MSM (e.g.

View Article and Find Full Text PDF

Background: COVID-19 vaccines are an effective tool to prevent illness due to SARS-CoV-2 infection. However, infection after vaccination still occurs. We evaluated all infections identified among recipients of either the Pfizer-BioNTech or Moderna COVID-19 vaccine in five U.

View Article and Find Full Text PDF
Article Synopsis
  • - Monkeypox, which originates from an orthopoxvirus and is commonly found in Africa, has led to a public health emergency in the U.S. since its outbreak began in May 2022, with over 2,891 cases reported by late July 2022.
  • - The majority of cases (99%) are among men, with a high correlation to male-to-male sexual or intimate contact, and there are significant disparities among racial and ethnic groups, particularly among non-Hispanic White, Hispanic, and Black populations.
  • - The CDC and health agencies are focusing their response on enhancing testing, treatment, and vaccination, particularly for gay and bisexual men who are significantly impacted, while emphasizing the importance of equity and
View Article and Find Full Text PDF

Previous reports of COVID-19 case, hospitalization, and death rates by vaccination status indicate that vaccine protection against infection, as well as serious COVID-19 illness for some groups, declined with the emergence of the B.1.617.

View Article and Find Full Text PDF

Background: With the emergence of the delta variant, the United States experienced a rapid increase in Covid-19 cases in 2021. We estimated the risk of breakthrough infection and death by month of vaccination as a proxy for waning immunity during a period of delta variant predominance.

Methods: Covid-19 case and death data from 15 U.

View Article and Find Full Text PDF

COVID-19 vaccine breakthrough infection surveillance helps monitor trends in disease incidence and severe outcomes in fully vaccinated persons, including the impact of the highly transmissible B.1.617.

View Article and Find Full Text PDF